News

RTI Surgical Enhances Portfolio with Collagen Solutions Buyout

RTI Surgical Enhances Portfolio with Collagen Solutions Buyout

RTI Surgical Enhances Portfolio with Collagen Solutions Buyout

RTI Surgical (RTI) has made a significant move in the regenerative medicine field by successfully acquiring Collagen Solutions, a distinguished supplier of engineered medical-grade collagen and xenograft tissue. This strategic acquisition was officially completed recently and is set to heighten RTI’s capabilities in providing advanced biomaterials.

Expanding Capabilities in Regenerative Medicine

This acquisition empowers RTI Surgical to expand its already comprehensive portfolio, complementing the previous acquisition of Cook Biotech earlier. By adding specialized bovine and porcine collagen materials, RTI can significantly enhance its market offerings in thriving therapeutic areas. Focused segments include cardiac, sports medicine, orthopedics, as well as plastic and reconstructive surgery, fostering innovative solutions that are critical in patient care.

Innovative Solutions for Medical Professionals

RTI Surgical has positioned itself as a forward-thinking Contract Development and Manufacturing Organization (CDMO). Collaborating closely with Original Equipment Manufacturers (OEMs), RTI is dedicated to identifying specific clinical challenges and providing tailored solutions that not only promote healing but also ensure quicker recovery times for patients. Their expertise in various medical fields has made them a trusted partner for many healthcare providers.

Collagen Solutions Overview

Collagen Solutions, based in Eden Prairie, Minnesota, with additional facilities in the U.K. and New Zealand, brings extensive experience and technology in collagen products to the RTI family. This combination signifies over 50 years of collective experience dedicated to improving patient outcomes through advanced medical innovations.

Shared Vision for Patient Care

Both companies share a common goal: to revolutionize patient care through innovative and effective regenerative medicine solutions. This partnership will not only enhance RTI’s product offerings but will also provide broader access to cutting-edge treatments for patients worldwide.

Commitment to Innovation and Excellence

As RTI Surgical continues to forge ahead in its mission, the company remains unwavering in its dedication to excellence in product development and patient safety. The integration of Collagen Solutions is a crucial step in RTI's strategy to lead in regenerative medicine.

Manufacturing Facilities and Expertise

The company has made significant investments in manufacturing facilities, located both in the United States and Europe, to ensure that they can meet the growing demand for high-quality medical products. With a view to the future, RTI Surgical is focused on refining its processes to enhance production efficiency while maintaining stringent quality control.

Future Growth and Development

This acquisition signals exciting new opportunities for RTI Surgical as they are now better positioned to address the evolving needs of the medical community. The commitment to research and development demonstrates RTI's ambition to remain at the forefront of innovative healthcare solutions.

Contact Information for Inquiries

For further information regarding the acquisition or any inquiries, RTI Surgical invites individuals and companies to reach out. Media contact Amelia Bell is available for communications at +1 386.418.5100.

Frequently Asked Questions

What is the significance of RTI Surgical's acquisition of Collagen Solutions?

This acquisition enhances RTI's market position by diversifying its product offerings in regenerative medicine and providing access to specialized collagen materials.

How does this acquisition benefit patients?

The acquisition allows RTI to offer advanced solutions that promote faster healing and improved recovery for patients undergoing various medical procedures.

Where are the manufacturing facilities of RTI Surgical located?

RTI Surgical has manufacturing facilities in both the United States and Europe, ensuring a robust supply of medical products.

What markets does RTI Surgical serve?

RTI Surgical serves critical segments such as cardiac, sports medicine, orthopedics, and plastic and reconstructive surgery, focusing on both innovation and patient care.

Who can be contacted for more information regarding RTI's operations?

Individuals can contact Amelia Bell at RTI Surgical for further inquiries related to the company and its acquisitions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MedStar's Same-Day Test Puts Stroke Drugs on Notice

Updated Category News Views 40

A five-hour lab result can matter more than another glossy precision-medicine slogan. MedStar Health says it is using same-day genetic testing for patients with ischemic stroke, giving clinicians information before discharge that previously often arrived more than a week later. That is a practical change, not science-fiction wallpaper: a treatment decision gets made while...

Continue Reading
Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 0

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead

Updated Category News Views 117

A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...

Continue Reading
Century Lithium Clears a Crucial Nevada Permit Gate

Updated Category News Views 65

Permitting news rarely rings a cash register, but it can stop one from being bolted shut. Century Lithium has received confirmation from the Bureau of Land Management’s Tonopah Field Office that baseline studies for its wholly owned Angel Island lithium project in Esmeralda County, Nevada, are complete. The agency also set the project on the Environmental Impact...

Continue Reading
RAN Rebound Gains Speed, but 2027 Still Looks Flat

Updated Category News Views 138

Radio gear finally caught a pulse in the third quarter, and that matters after more than two years of contraction. Dell’Oro Group says worldwide Radio Access Network revenue rose at a mid-single-digit year-over-year rate in 3Q 2026, the market’s strongest quarterly growth in nearly five years. That is better than expected, which is a welcome change in a telecom...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 143

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 85

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Accredited Debt Relief Earns Personalized Honor in 2026

Updated Category News Views 45

A High Score Is Useful, Not a Free Pass Debt relief rankings can get awfully shiny when a company has a good week, but this one has some actual detail behind it. USA Today named Accredited Debt Relief its best provider for personalized debt relief in its 2026 review, handing the company a 94 out of 100. The ranking was published November 11 and updated November 12, and...

Continue Reading
Qiandaohu Whisky Film Puts Craft Before Market Hype

Updated Category News Views 59

Three Distillers, One Very Large Question Whisky does not become world-class because a camera crew found a pretty shoreline. That is the blunt truth sitting underneath this Nov. 19, 2026 documentary release from CCTV+. The film follows three international distillers working at three separate whisky distilleries along Qiandaohu, while also lingering on their day-to-day...

Continue Reading

Top 5 Most Recently Viewed Articles

A&K Robotics Strengthens Leadership with Melonee Wise's Expertise

Updated Category News Views 289

Leadership Expansion at A&K Robotics A&K Robotics, a frontrunner in the autonomous micromobility sector, is excited to welcome Melonee Wise to its Board of Advisors. With over twenty years of rich experience in developing robotic technologies, Wise is poised to offer invaluable insights as the company continues to grow its influence worldwide. Advancing Mobility Through...

Continue Reading
Lavior Welcomes Ryan Shilling as New VP of Sales for U.S.

Updated Category News Views 147

Lavior Welcomes Ryan Shilling as New VP of Sales for U.S. Healthcare Expertise to Drive Growth and Patient-Centered Innovation Lavior, an innovator in advanced healing solutions, proudly announces the appointment of Ryan Shilling as Vice President of Sales for the U.S. market. With over 15 years of leadership experience in various healthcare sectors, Shilling is set to...

Continue Reading
Tesla's Cybertruck Delivery Plans Set to Launch in Canada

Updated Category News Views 372

Tesla Gears Up for Cybertruck Deliveries in Canada Tesla Inc. (NASDAQ: TSLA) is approaching an exciting milestone as it plans to start delivering its much-anticipated Cybertruck in Canada shortly. Recent updates on social media suggest that the event could happen as early as next week, thrilling prospective owners. Exciting Customer Announcements On social media platform...

Continue Reading
Borregaard ASA Announces Ex-Dividend Trading Notification

Updated Category News Views 191

Borregaard ASA Ex-Dividend Trading Insights Today marks the beginning of a new trading phase for Borregaard ASA as its shares are now officially traded ex-dividend at NOK 4.25 per share. This means that investors purchasing shares at this point will not receive the forthcoming dividend, which can influence buying decisions in the market. Understanding Ex-Dividend Dates...

Continue Reading
Key Legal Notice for Charter Communications' Shareholders

Updated Category News Views 189

Current Updates on Charter Communications, Inc. Charter Communications, Inc. (NASDAQ: CHTR) has been generating significant attention as it faces an ongoing class action lawsuit regarding securities fraud. This legal proceeding serves to remind shareholders of their rights and the timelines that are critical for participation. With the stakes involved, it is vital for...

Continue Reading